Single-Cell Multimodal Profiling Reveals a Novel CD26 + Fibroblast Subpopulation in Atherosclerosis
Preprint
Abstract
Background: Atherosclerosis involves complex interactions between lipids, immune cells, vascular smooth muscle cells (VSMCs), and fibroblasts within the arterial wall. While significant advances in single-cell technologies have shed light on the roles of immune cells and VSMCs in plaque development, fibroblasts remain underexplored, leaving critical gaps in understanding their contributions to disease progression and plaque stability. Comprehensive characterization of fibroblast phenotypes in atherosclerosis is essential to unravel their diverse functions and to distinguish between subsets that may play protective versus pathogenic roles in the disease process. Methods: Here, we utilized CITE-seq (Cellular Indexing of Transcriptomes and Epitopes by Sequencing) to comprehensively profile fibroblast diversity in a mouse model of atherosclerosis. Mice were fed an atherogenic diet for 0, 8, 19, and 26 weeks, representing distinct stages of disease progression, enabling a detailed phenotypic characterization of fibroblasts throughout the course of atherosclerosis development. Results: We identified four distinct fibroblast subpopulations, including a myofibroblast population closely resembling VSMC-derived chondromyocytes. The proportions of these fibroblast subsets exhibited a modest decline as atherosclerosis progressed. Through multimodal analysis, we identified CD26 as a highly expressed and specific marker for one of these fibroblast subpopulations, distinguishing it from other subsets. Using a combination of flow cytometry and immunohistochemistry, we demonstrated that CD26 + fibroblasts predominantly reside in the adventitia of healthy arteries. During atherosclerosis progression, these cells expand into the intima and primarily localize within the fibrous cap of the lesion. Conclusions: Our multi-omic analysis highlights the phenotypic diversity and dynamic changes of fibroblasts during atherosclerosis progression. Among these, CD26+ fibroblasts emerge as a distinct subpopulation that expands within atherosclerotic lesions and may play a critical role in promoting plaque stability through their migration into the fibrous cap.Keywords
All Related Versions
- Published version: Arteriosclerosis, Thrombosis, and Vascular Biology, 45 (8), 1389.
This publication has 27 references indexed in Scilit:
- The mechanisms of ferroptosis and its role in atherosclerosisBiomedicine & Pharmacotherapy, 2024
- Integrative single-cell meta-analysis reveals disease-relevant vascular cell states and markers in human atherosclerosisCell Reports, 2023
- CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancerNature Communications, 2023
- Sirtuins in atherosclerosis: guardians of healthspan and therapeutic targetsNature Reviews Cardiology, 2022
- Cross-tissue organization of the fibroblast lineageNature, 2021
- The changing landscape of atherosclerosisNature, 2021
- Single-cell immune landscape of human atherosclerotic plaquesNature Medicine, 2019
- Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysisNature Medicine, 2019
- Simultaneous epitope and transcriptome measurement in single cellsNature Methods, 2017
- Genetic lineage tracing defines myofibroblast origin and function in the injured heartNature Communications, 2016